Table 2.
Presenting baseline demographics of TAK patients with RAI
| Patient demographics | Value |
|---|---|
| Patients, n | |
| Total | 37 |
| Cambridge, UK | 10 |
| Lund, Sweden | 6 |
| Toronto, Canada | 21 |
| Unilateral RAI, n (%) | 18 (49) |
| Bilateral RAI, n (%) | 19 (51) |
| Female, n (%) | 33 (89) |
| Age, median (IQR), years | 27 (16–38) |
| Ethnicity, n (%) | |
| White | 20 (54) |
| Asian | 7 (19) |
| Black | 3 (8) |
| Othera | 7 (19) |
| Disease duration, median (IQR), years | 0.5 (0.2–2) |
| ACR classification met, n (%) | 29 (78) |
| Disease features, n (%) | |
| Asymmetrical blood pressure | 22 (59) |
| Reduced brachial pulse | 19 (51) |
| Limb claudication | 16 (43) |
| Bruit | 13 (35) |
| Disease activity, ITAS2010, median (IQR) | 13 (9–15) |
| Comorbidities, n (%) | |
| Hypertension | 19 (51) |
| SpAb | 6 (16) |
| Treated tuberculosis | 3 (8) |
| Structural renal disease | 2 (5) |
| Prior treatments, n (%) | |
| None | 14 (38) |
| Systemic treatments | 21 (57) |
| GC only | 8 (22) |
| GC + more than one ISD | 10 (27) |
| IFX ± GC + ISD | 3 (8) |
| Endovascular intervention | 2 (5) |
| CABG | 1 (3) |
a
Other: Arabic (2), Hispanic (2), South Asian (2), undefined (1).
b
SpA: IBD, psoriasis, seronegative inflammatory arthritis.
CABG: coronary artery bypass graft; IFX: infliximab.